Data / Form D filings / Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc.: Form D filings
Poseida Therapeutics, Inc., a biotechnology company in San Diego, CA, filed 5 Form D notices with the SEC between 2015 and 2023. The latest, on August 11, 2023, reports $25 million sold of a $25 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9390 TOWNE CENTRE DRIVE, SUITE 200, San Diego, CA, 92121
- Phone
- (858) 779-3100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1661460
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | New notice | $24,999,999 | $24,999,999 | 1 | Aug 7, 2023 | sec.gov | |
| Apr 22, 2019 | New notice | $150,000,000 | $142,120,007 | $7,879,993 | 17 | Mar 19, 2019 | sec.gov |
| Apr 3, 2018 | New notice | $30,499,990 | $30,499,990 | 7 | Mar 19, 2018 | sec.gov | |
| Aug 3, 2017 | New notice | $15,000,000 | $11,160,002 | $3,839,998 | 16 | Jul 21, 2017 | sec.gov |
| Dec 24, 2015 | New notice | $36,033,230 | $23,033,232 | $12,999,998 | 14 | Dec 15, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Harry J. Leonhardt | Executive Officer | |
| Mark J. Gergen | Executive Officer, Director | |
| Johanna M. Mylet | Executive Officer | |
| Luke M. Corning | Director | |
| Cynthia M. Collins | Director | |
| Marcea B. Lloyd | Director | |
| Brent J. Warner | Executive Officer | |
| Charles M. Baum | Director | |
| Kristin J. Yarema | Executive Officer | |
| John B. Schmid | Director | |
| Rafael J. Amado | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 7, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Poseida Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.